Simethicone ( DrugBank: Simethicone )

2 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
96	Crohn disease	1

13. Multiple sclerosis/Neuromyelitis optica

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02217982 (ClinicalTrials.gov)	July 2014	30/7/2014	Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation	A Pilot Study to Assess Dimethyl Fumarate (Tecfidera) Related GI Symptom Mitigation Via Food Bolus A ...	Relapsing Remitting Multiple Sclerosis	Drug: Simethicone;Drug: Loperamide;Other: Peanut Butter	Rocky Mountain MS Research Group, LLC	Biogen	Terminated	18 Years	N/A	All	5	Phase 4	United States

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-DDT-14004402	2014-03-28	2014-03-09	The study of small bowel cleaning by using senna, 20% mannitol, simethicone and three days fasting	The study of small bowel cleaning by using senna, 20% mannitol, simethicone and three days fasting	Obscure gastrointestinal bleeding, iron deficiency anemia , Suspected Crohn’s disease, Suspected sma ...	Group A:20%Mannitol, 0.9% saline;Group B:20%Mannitol, 0.9% saline?simethicone;Group C:20%Mannitol, 0 ...	Sanming First Affiliated Hospital of Fujian Medical University	NULL	Completed	10	85	Both	Group A:60;Group B:60;Group C:60;	4 (Phase 4 study)	China